Blue Jet Healthcare’s Board of Directors approved the unaudited standalone financial results for Q2 (July-September) and the half-year ended September 30, 2025. The company reported a profit for the period of ₹521.36 million for the quarter and ₹1,433.07 million for the half-year ended September 30, 2025. The meeting was held on November 4, 2025.
Q2 Financial Highlights
The Board of Directors of Blue Jet Healthcare has approved the unaudited standalone financial results for the second quarter (Q2) and half-year ended September 30, 2025.
Key financial figures include:
- Revenue from Operations: ₹1,654.81 million for Q2 and ₹5,202.39 million for the half-year.
- Other Income: ₹242.71 million for Q2 and ₹325.25 million for the half-year.
- Total Income: ₹1,897.52 million for Q2 and ₹5,527.64 million for the half-year.
- Profit for the period: ₹521.36 million for Q2 and ₹1,433.07 million for the half-year.
- Total Comprehensive Income: ₹522.47 million for Q2 and ₹1,434.18 million for the half-year.
- Earnings per Share (EPS): ₹3.01 for Q2 and ₹8.26 for the half-year.
Financial Performance Overview
The company’s expenses totaled ₹1,210.25 million for the quarter and ₹3,611.77 million for the half-year ended September 30, 2025. This resulted in a profit before tax of ₹687.27 million for the quarter and ₹1,915.87 million for the half-year.
The Board meeting to approve these results occurred on November 4, 2025.
Cash Flow Statement Summary
Key figures from the cash flow statement include:
- Net Cash generated from Operating Activities: ₹2,071.87 million for the six months ended September 30, 2025.
- Net Cash used in Investing Activities: ₹(1,646.32) million for the six months ended September 30, 2025.
- Net Cash used in Financing Activities: ₹(85.36) million for the six months ended September 30, 2025.
- Net Increase/ (Decrease) in Cash and Cash Equivalents: ₹340.19 million for the six months ended September 30, 2025.
- Cash and Cash Equivalents at the end of the period: ₹669.98 million.
Assets and Liabilities Snapshot
As of September 30, 2025, Blue Jet Healthcare reported:
- Total Assets: ₹15,274.60 million.
- Total Equity: ₹346.93 million (Equity Share Capital) and ₹12,210.24 million (Other Equity).
Source: BSE
